This Hematology Research Training Program is committed to training physician-scientists for careers in academic medicine and hematology research. Our program strives to balance sufficient structure to ensure rigor of the training experience with sufficient flexibility to ensure that individual trainee career goals can be met. We accomplish this by bringing together a Fellowship Program and Research Training Program that are closely integrated, in a rich intellectual environment with a supportive resource-rich infrastructure, with a faculty that is highly-qualified and enthusiastic and dedicated to development of young investigators. Our faculty roster includes twenty-seven senior mentors and six Junior mentors. Their areas of expertise and research interests encompass: Biomedical Ethics, Transfusion Medicine, Vascular Biology (including endothelial biology and angiogenesis, hemostasis and thrombosis, blood cell biology and immunology, and sickle disease), and Stem Cell Malignancy (including hematologic malignancies, hematopoiesis, stem cell biology, marrow transplantation, and aspects of oncology that are directly relevant to hematologic disease such as signal transduction, cell cycle control, adhesion science). This Training Grant now has new leadership, and a number of changes have already been made in the Program?s structure, style, emphasis and philosophy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007062-27
Application #
6622774
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Chang, Henry
Project Start
1982-07-01
Project End
2007-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
27
Fiscal Year
2003
Total Cost
$412,400
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Goldberg, Michael F; Roeske, Elizabeth K; Ward, Lauren N et al. (2018) Salmonella Persist in Activated Macrophages in T Cell-Sparse Granulomas but Are Contained by Surrounding CXCR3 Ligand-Positioned Th1 Cells. Immunity 49:1090-1102.e7
Don Yun, Hyun; Felices, Martin; Vallera, Daniel A et al. (2018) Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells. Blood Adv 2:1580-1584
Shaban, Nadine M; Shi, Ke; Lauer, Kate V et al. (2018) The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism. Mol Cell 69:75-86.e9
Webber, Beau R; O'Connor, Kyle T; McElmurry, Ron T et al. (2017) Rapid generation of Col7a1-/- mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells. Lab Invest 97:1218-1224
Matta, B M; Reichenbach, D K; Blazar, B R et al. (2017) Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses. Am J Transplant 17:320-327
Skvarova Kramarzova, Karolina; Osborn, Mark J; Webber, Beau R et al. (2017) CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells. Int J Mol Sci 18:
Dourado, Keina M C; Baik, June; Oliveira, Vanessa K P et al. (2017) Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models. Blood 129:2526-2536
Bastian, T W; Duck, K A; Michalopoulos, G C et al. (2017) Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development. J Thromb Haemost 15:565-574
Matson, Jacob Peter; Dumitru, Raluca; Coryell, Philip et al. (2017) Rapid DNA replication origin licensing protects stem cell pluripotency. Elife 6:
Davis, Zachary B; Vallera, Daniel A; Miller, Jeffrey S et al. (2017) Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy. Semin Immunol 31:64-75

Showing the most recent 10 out of 102 publications